CoChat
Sign Up
Cited by 104Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and Mutations

The DOI matches its Crossref record.

Association of tumour mutational burden with outcomes in patients with select advanced solid tumours treated with pembrolizumab in KEYNOTE-158

Open access
Marabelle, A., Fakih, M.G., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., Chung, H.C., Kindler, H.L., Lopez-Martin, J.A., Miller, W., Italiano, A., Kao, S., Piha-Paul, S.A., Delord, J.-P., McWilliams, R.R., Aurora-Garg, D., Chen, M., Jin, F., Norwood, K., Bang, Y.-J.·2019·Annals of Oncology
DOI 10.1093/annonc/mdz253.018
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1093/annonc/mdz253.018

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

Sorted by citations

Items 101–104 of 104

Related

See all

Metadata

Authors
Marabelle, A., Fakih, M. G., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., Chung, H. C., Kindler, H. L., Lopez-Martin, J. A., Miller, W., Italiano, A., Kao, S., Piha-Paul, S. A., Delord, J.-P., McWilliams, R. R., Aurora-Garg, D., Chen, M., Jin, F., Norwood, K., & Bang, Y.-J.
Affiliations
  • Inserm (FR)
  • City Of Hope National Medical Center (US)
  • Royal Marsden NHS Foundation Trust (GB)
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
  • Kindai University (JP)
  • Yonsei University (KR)
  • University of Chicago (US)
  • Research Institute Hospital 12 de Octubre (ES)
  • Jewish General Hospital (CA)
  • Institut Bergonié (FR)
  • Chris O’Brien Lifehouse (AU)
  • The University of Texas MD Anderson Cancer Center (US)
  • Institut universitaire du cancer de Toulouse Oncopole (FR)
  • Mayo Clinic (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Seoul National University (KR)
ORCID
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2019-10
Volume
30
Pages
v477-v478
ISSN
0923-7534 (ISSN-L)
DOI
10.1093/annonc/mdz253.018
OpenAlex
W2978458313
Cited by
104
References
0
Citations by year
2026: 4 · 2025: 9 · 2024: 4 · 2023: 10 · 2022: 14 · 2021: 35 · 2020: 27
FWCI
7.94
Type
journal article
Language
en
Open access
Licence
Locations
Annals of Oncology (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
Keywords
tumor mutational burden, pembrolizumab, immune checkpoint inhibitors, advanced solid tumors, predictive biomarkers, treatment outcomes, KEYNOTE-158, melanoma, non-small cell lung cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review